SeoSKLeeJHChonSJet al.Trichostatin A induces NAG-1 expression and apoptosis in human endometriotic stromal cells. Reprod Sci. 2017:1933719117741372.
2.
SeoSKNamAJeonYEChoSChoiYSLeeBS. Expression and possible role of non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) in the human endometrium and endometriosis. Hum Reprod. 2010;25(12):3043–3049.
3.
KawanoYNasuKLiHet al.Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod. 2011;26(9):2486–2498.
4.
WuYStarzinski-PowitzAGuoSW. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Reprod Sci. 2007;14(4):374–382.
5.
WuYGuoSW. Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol. 2007;135(1):88–93.
6.
WuYGuoSW. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):198–203.
7.
ChenYCaiSWangJXuM. Valproic acid-induced histone acetylation suppresses CYP19 gene expression and inhibits the growth and survival of endometrial stromal cells. Int J Mol Med. 2015;36(3):725–732.
8.
LuYNieJLiuXZhengYGuoSW. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010;25(4):1014–1025.
9.
LiuMLiuXZhangYGuoSW. Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats. Reprod Sci. 2012;19(4):360–373.
10.
XishiLLeiYGuoSW. Valproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. 2010;17(10):904–912.
11.
TafiELeone Roberti MaggioreUAlessandriFet al.Advances in pharmacotherapy for treating endometriosis. Expert Opin Pharmacother. 2015;16(16):2465–2483.
